3 completed, 1 terminated. 1 Not applicable, 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Intervention C: new trials by email Literature Review of Intervention C trials Research Report on Intervention C
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment for COVID-19 in High-Risk Adult Outpatients Ascorbic Acid, Hydroxychloroquine Sulfate, Azithromycin - COVID-19, SARS-CoV-2 | Phase 2 / Phase 3 | Terminated | University of Washington | 289 | 2020-04-16 | 2022-08-08 |
| Isomaltulose VS Sucrose - Postprandial Effect on Incretin Profile and Second Meal Effect Intervention A, Intervention B, Intervention C - Diabetes Mellitus, Type 2, Metabolic Syndrome | Not applicable | Completed | German Institute of Human Nutrition | 50 | 2016-11-05 | 2020-06-24 |
| A Safety and Tolerability Study of Administration of PSD502 Intervention A, Intervention B, Intervention C - Premature Ejaculation | Phase 1 | Completed | Plethora Solutions Ltd | 21 | 2009-12-01 | 2016-08-10 |
| Fosamprenavir in Pts With Hepatic Impairment Intervention A Standard dose, Intervention B Reduced Dose, Intervention C - Infection, Human Immunodeficiency Virus | Completed | GlaxoSmithKline | 167 | 2009-01-01 | 2013-05-07 |
Acquired Immunodeficiency Syndrome (1) · COVID-19 (1) · Diabetes Mellitus, Type 2 (1) · Infections (1) · Metabolic Syndrome (1) · Premature Ejaculation (1)
German Institute of Human Nutrition (1) · GlaxoSmithKline (1) · Plethora Solutions Ltd (1) · University of Washington (1)
Germany (1) · United Kingdom (1) · United States (1)
Christine Johnston, MD, MPH (1)